Journal of Nuclear Medicine: 55 (12)

About the Cover

December 1, 2014; Volume 55,Issue 12

Cover image

¹⁸F-mefway exhibits favorable in vivo properties for serotonin 5-HT_1A receptor measurements in humans. It is an attractive PET radiotracer for neuropsychiatric disorders and drug intervention. See page 1973.

In this issue

Issue highlights

Perceived Misinterpretation Rates in Oncologic ¹⁸F-FDG PET/CT Studies: A Survey of Referring Physicians
Comparison and Prognostic Validation of Multiple Methods of Quantification of Myocardial Blood Flow with ⁸²Rb PET
First-in-Human Evaluation of ¹⁸F-Mefway, a PET Radioligand Specific to Serotonin-1A Receptors
Multimodality Imaging of Alzheimer Disease and Other Neurodegenerative Dementias

MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [¹⁷⁷Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
Prediction of ¹⁷⁷Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
Renal and Multiorgan Safety of ¹⁷⁷Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections

More...

Main menu

User menu

Search

About the Cover

Cover image

In this issue

Issue highlights

Jump to